<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="/prwebFeeds.xsl"?>
<rss version="2.0">
  <channel>
    <title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
    <link>http://www.prweb.com</link>
    <description>PRWeb.com Press Release Feed - Press Releases</description>
    <language>en</language>
    <image>
      <title>PRWeb Distribution Newswire</title>
      <url>http://www.prweb.com/images_v4/prweb_logo_hv.jpg</url>
      <link>http://www.prweb.com</link>
      <width>200</width>
      <height>46</height>
    </image>
    <managingEditor>xml@emediawire.com</managingEditor>
    <webMaster>xml@emediawire.com</webMaster>
    <ttl>30</ttl>

<item>
    <title>SpectraDigital Corporation to Begin Phase 1 Pilot of HIV Diagnostic Tool: Initiation of First US Clinical Trial for &#8220;HIV SpectraPoint&#8221;(tm) Assay.</title>
    <link>http://www.prweb.com/releases/2004/11/prweb176707.htm</link>
    <description>
        <![CDATA[  <P>SpectraDigital Corporation, has begun a Phase I clinical pilot of its HIV SpectraPoint&#8482; diagnostic system with AIDS ReSearch Alliance of America (ARA).  Up to 40 patients will receive a standard phenotype test as well as the antiviral efficacy test generated by the new HIV SpectraPoint assay.  The system could allow physicians to receive results within 24 hours, allowing essential treatment decisions to be made before the virus can develop new, unseen resistance patterns. (PRWeb Nov 9, 2004)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2004/11/prweb176707.htm">http://www.prweb.com/releases/2004/11/prweb176707.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2004/11/prweb176707.htm</guid>
</item>

</channel>
</rss>